Brokerages forecast that Proto Labs, Inc. (NYSE:PRLB) will report sales of $91.75 million for the current fiscal quarter, Zacks Investment Research reports. Two analysts have issued estimates for Proto Labs’ earnings. The lowest sales estimate is $91.60 million and the highest is $91.89 million. Proto Labs posted sales of $72.35 million during the same quarter last year, which would indicate a positive year over year growth rate of 26.8%. The firm is scheduled to announce its next quarterly earnings results on Thursday, February 8th.

On average, analysts expect that Proto Labs will report full year sales of $91.75 million for the current fiscal year, with estimates ranging from $338.00 million to $342.20 million. For the next fiscal year, analysts forecast that the business will post sales of $438.39 million per share, with estimates ranging from $438.27 million to $438.50 million. Zacks Investment Research’s sales averages are a mean average based on a survey of sell-side analysts that follow Proto Labs.

Proto Labs (NYSE:PRLB) last issued its quarterly earnings results on Thursday, October 26th. The industrial products company reported $0.56 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.52 by $0.04. The company had revenue of $88.10 million for the quarter, compared to analysts’ expectations of $85.68 million. Proto Labs had a return on equity of 12.62% and a net margin of 15.00%. The firm’s revenue for the quarter was up 12.7% on a year-over-year basis. During the same period in the prior year, the firm earned $0.51 earnings per share.

Several brokerages recently weighed in on PRLB. Piper Jaffray Companies reaffirmed a “hold” rating and issued a $84.00 price target on shares of Proto Labs in a research note on Thursday. Craig Hallum set a $92.00 price target on Proto Labs and gave the stock a “hold” rating in a research note on Monday, November 27th. Zacks Investment Research raised Proto Labs from a “hold” rating to a “buy” rating and set a $96.00 price target on the stock in a research note on Friday, November 3rd. Finally, BidaskClub cut Proto Labs from a “strong-buy” rating to a “buy” rating in a research note on Friday, October 6th. Three research analysts have rated the stock with a hold rating and two have given a buy rating to the company. Proto Labs has a consensus rating of “Hold” and an average price target of $79.25.

In other news, VP John B. Tumelty sold 13,556 shares of the stock in a transaction on Wednesday, November 22nd. The stock was sold at an average price of $92.07, for a total value of $1,248,100.92. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, VP Robert Bodor sold 4,000 shares of the stock in a transaction on Monday, December 11th. The stock was sold at an average price of $94.79, for a total value of $379,160.00. Following the completion of the sale, the vice president now directly owns 20,578 shares in the company, valued at $1,950,588.62. The disclosure for this sale can be found here. Over the last three months, insiders sold 19,056 shares of company stock worth $1,762,726. Insiders own 7.78% of the company’s stock.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Victory Capital Management Inc. boosted its position in shares of Proto Labs by 17.7% during the second quarter. Victory Capital Management Inc. now owns 2,323 shares of the industrial products company’s stock valued at $156,000 after buying an additional 349 shares during the last quarter. Pinebridge Investments L.P. boosted its position in shares of Proto Labs by 0.9% during the second quarter. Pinebridge Investments L.P. now owns 3,212 shares of the industrial products company’s stock valued at $216,000 after buying an additional 29 shares during the last quarter. California Public Employees Retirement System purchased a new stake in shares of Proto Labs during the first quarter valued at $230,000. Advisor Group Inc. boosted its position in shares of Proto Labs by 3.6% during the second quarter. Advisor Group Inc. now owns 3,409 shares of the industrial products company’s stock valued at $230,000 after buying an additional 119 shares during the last quarter. Finally, Amalgamated Bank purchased a new stake in shares of Proto Labs during the second quarter valued at $230,000.

Shares of Proto Labs (NYSE PRLB) traded up $1.40 during mid-day trading on Monday, reaching $100.35. The company had a trading volume of 357,300 shares, compared to its average volume of 193,585. The stock has a market capitalization of $2,673.93, a PE ratio of 57.34, a price-to-earnings-growth ratio of 2.53 and a beta of 1.06. Proto Labs has a 12 month low of $48.00 and a 12 month high of $101.00.

TRADEMARK VIOLATION WARNING: “Zacks: Brokerages Expect Proto Labs, Inc. (PRLB) Will Post Quarterly Sales of $91.75 Million” was first reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this story on another site, it was stolen and reposted in violation of United States & international copyright and trademark legislation. The legal version of this story can be viewed at https://www.thecerbatgem.com/2017/12/18/zacks-brokerages-expect-proto-labs-inc-prlb-will-post-quarterly-sales-of-91-75-million.html.

Proto Labs Company Profile

Proto Labs, Inc is an e-commerce driven digital manufacturer of on-demand three dimensional (3D) printed, computer numerical control (CNC) machined and injection-molded custom parts for prototyping and short-run production. The Company’s geographic segments include the United States, Europe and Japan.

Get a free copy of the Zacks research report on Proto Labs (PRLB)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Proto Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proto Labs and related companies with MarketBeat.com's FREE daily email newsletter.